|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 256.80 CHF | -2.36% |
|
-1.23% | +0.51% |
| 07-10 | ROCHE HOLDINGS AG : Buy rating from UBS | ZD |
| 07-09 | Swiss Market Index Closes Higher; SGS Shares Down | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCHE HOLDING AG | Other Pharmaceuticals | -2.36% | -1.23% | +0.51% | +0.78% | -23.78% | 259B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ROG Stock
- Charts Roche Holding AG
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition